Insider Transactions in Q1 2025 at Aardvark Therapeutics, Inc. (AARD)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Decheng Capital Global Life Sciences Fund Iv, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,250,000
+28.46%
|
$20,000,000
$16.0 P/Share
|
|
Feb 14
2025
|
Decheng Capital Global Life Sciences Fund Iv, L.P. |
BUY
Conversion of derivative security
|
Indirect |
2,667,299
+50.0%
|
-
|
|
Feb 14
2025
|
Jeffrey Chi |
BUY
Conversion of derivative security
|
Indirect |
133,364
+50.0%
|
-
|
|
Feb 14
2025
|
Vickers Venture Fund Vi Pte LTD |
BUY
Conversion of derivative security
|
Indirect |
2,050,902
+33.39%
|
-
|
|
Feb 14
2025
|
Tien Li Lee Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
16,542
+1.09%
|
$264,672
$16.0 P/Share
|
|
Feb 14
2025
|
Tien Li Lee Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
41,303
+2.72%
|
-
|
|
Feb 14
2025
|
Nelson Sun Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+9.13%
|
$160,000
$16.0 P/Share
|
|
Feb 14
2025
|
Nelson Sun Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
7,001
+7.26%
|
-
|
|
Feb 14
2025
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
187,500
+15.95%
|
$3,000,000
$16.0 P/Share
|
|
Feb 14
2025
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
800,189
+50.0%
|
-
|